Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
Brandon F. Keele, Elena E. Giorgi, Jesus F. Salazar-Gonzalez, Julie M. Decker, Kimmy T. Pham, Maria G. Salazar, Chuanxi Sun, Truman B. Grayson, Shuyi Wang, Hui Li, Xiping Wei, Chunlai Jiang, Jennifer Kirchherr, Feng Gao, Jeffery A. Anderson, Li‐Hua Ping, Ronald I. Swanstrom, Georgia D. Tomaras, William A. Blattner, Paul Goepfert, J Michael Kilby, Michael S. Saag, Eric Delwart, Michael Paul Busch, Myron S. Cohen, David C. Montefiori, Barton F. Haynes, Brian K. Gaschen, Gayathri S. Athreya, Ha Y. Lee, Natasha T. Wood, Cathal Seoighe, Alan S. Perelson, Tanmoy Bhattacharya A, Bette Korber, Beatrice H. Hahn, George M. Shaw
Proceedings of the National Academy of Sciences · 2008 · 1,977 citationsOpen access
Abstract
The precise identification of the HIV-1 envelope glycoprotein (Env) responsible for productive clinical infection could be instrumental in elucidating the molecular basis of HIV-1 transmission and in designing effective vaccines. Here, we developed a mathematical model of random viral evolution and, together with phylogenetic tree construction, used it to analyze 3,449 complete env sequences derived by single genome amplification from 102 subjects with acute HIV-1 (clade B) infection. Viral env genes evolving from individual transmitted or founder viruses generally exhibited a Poisson distribution of mutations and star-like phylogeny, which coalesced to an inferred consensus sequence at or near the estimated time of virus transmission. Overall, 78 of 102 subjects had evidence of productive clinical infection by a single virus, and 24 others had evidence of productive clinical infection by a minimum of two to five viruses. Phenotypic analysis of transmitted or early founder Envs revealed a consistent pattern of CCR5 dependence, masking of coreceptor binding regions, and equivalent or modestly enhanced resistance to the fusion inhibitor T1249 and broadly neutralizing antibodies compared with Envs from chronically infected subjects. Low multiplicity infection and limited viral evolution preceding peak viremia suggest a finite window of potential vulnerability of HIV-1 to vaccine-elicited immune responses, although phenotypic properties of transmitted Envs pose a formidable defense.
Cite this paper
Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T. B., Wang, S., Li, H., Wei, X., Jiang, C., Kirchherr, J., Gao, F., Anderson, J. A., Ping, L., Swanstrom, R. I., Tomaras, G. D., Blattner, W. A., … Shaw, G. M. (2008). Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proceedings of the National Academy of Sciences, 105(21), 7552–7557. https://doi.org/10.1073/pnas.0802203105
Read it with every claim anchored
Add this paper to a project, ask questions of it, and get answers that point to the exact passage.
Start freeRelated papers
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection2002
- The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets2014
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis1989
- Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line1999
- Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy1998
Metadata from OpenAlex (CC0). Citations are generated from the published record.